Open AccessP043 HEALTHCARE SERVICE UTILIZATION AND COSTS OF CERTOLIZUMAB PEGOL VERSUS INFLIXIMAB TREATMENT IN PATIENTS WITH CROHN’S DISEASE
Author(s) -
Joseph Tkacz,
Edward Lee,
Robert Löw,
Jeffrey C. Stark,
Mohamed Yassine,
Brenna L. Brady
Publication year - 2018
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izy019.049
Subject(s) - certolizumab pegol , medicine , infliximab , pharmacy , emergency medicine , disease , family medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom